Back to Journals » Biologics: Targets and Therapy » Volume 12

Two decades with omalizumab: what we still have to learn

Total article views   Abstract views HTML views PDF downloads Totals
12,392 Dovepress* 4,709 5,410+ 1,386 10,119
PubMed Central* 0 2,273 664 2,273
Totals 4,709 7,683 2,050 12,392
*Since 26 October 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 2 4

View citations on PubMed Central and Google Scholar